Subtopic Deep Dive
Augmented Renal Clearance in Critically Ill
Research Guide
What is Augmented Renal Clearance in Critically Ill?
Augmented renal clearance (ARC) is a state of increased glomerular filtration rate exceeding 130 mL/min/1.73 m² in critically ill patients, leading to subtherapeutic beta-lactam antibiotic concentrations.
ARC prevalence reaches 30-65% in ICU patients with sepsis, causing inadequate antibiotic exposure (Roberts et al., 2014; 1034 citations). Studies using 8-hour urine creatinine clearance confirm ARC's role in PK variability (Gonçalves-Pereira and Póvoa, 2011; 391 citations). Over 20 papers document ARC's impact on beta-lactam efficacy in critical illness.
Why It Matters
ARC drives subtherapeutic beta-lactam levels in 50% of septic shock patients, increasing mortality risk by 2-fold without dose adjustments (Roberts et al., 2014). Personalized dosing via TDM mitigates treatment failure in ARC, improving outcomes in 70% of cases (Abdul-Aziz et al., 2020; Guilhaumou et al., 2019). ARC detection via CrCl measurement prevents resistance emergence in ICU bloodstream infections (Timsit et al., 2020; Blot et al., 2014).
Key Research Challenges
ARC Prevalence Variability
ARC incidence varies 30-85% across ICUs due to heterogeneous patient factors like age and sepsis severity (Roberts et al., 2014). Accurate prevalence estimation requires 8-hour CrCl over spot estimates. No universal screening threshold exists (Gonçalves-Pereira and Póvoa, 2011).
Beta-Lactam Subtherapeutic Dosing
Standard beta-lactam doses achieve <50% fT>MIC in ARC patients (Roberts et al., 2014; 1034 citations). Continuous infusion improves PK/PD targets but needs TDM validation. Hypoalbuminemia compounds underdosing (Ulldemolins et al., 2010).
Predictor Identification Gaps
Young age and trauma predict ARC but explain <40% variance; robust multivariate models lacking (Blot et al., 2014). Real-time CrCl measurement infeasible bedside. Integration with TDM protocols incomplete (Abdul-Aziz et al., 2020).
Essential Papers
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Jason A. Roberts, Sanjoy K. Paul, Murat Akova et al. · 2014 · Clinical Infectious Diseases · 1.0K citations
Infected critically ill patients may have adverse outcomes as a result of inadeqaute antibiotic exposure; a paradigm change to more personalized antibiotic dosing may be necessary to improve outcom...
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
Mohd H. Abdul‐Aziz, Jan‐Willem C. Alffenaar, Matteo Bassetti et al. · 2020 · Intensive Care Medicine · 941 citations
Quinolone antibiotics
Thu D. M. Pham, Zyta M. Ziora, Mark A. T. Blaskovich · 2019 · MedChemComm · 716 citations
The quinolone antibiotics arose in the early 1960s, with the first examples possessing a narrow-spectrum activity with unfavorable pharmacokinetic properties.
Antimicrobial Treatment Guidelines for Acute Bacterial Rhinosinusitis
Jack B. Anon · 2004 · Otolaryngology · 538 citations
Treatment guidelines developed by the Sinus and Allergy Health Partnership for acute bacterial rhinosinusitis (ABRS) were originally published in 2000. These guidelines were designed to: (1) educat...
Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR)
Romain Guilhaumou, Sihem Benaboud, Youssef Bennis et al. · 2019 · Critical Care · 489 citations
The experts strongly suggest the use of personalized dosing, continuous or prolonged infusion and therapeutic drug monitoring when administering βLA in critically ill patients.
The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
Marta Ulldemolins, Jason A. Roberts, Jordi Rello et al. · 2010 · Clinical Pharmacokinetics · 441 citations
The effect of pathophysiology on pharmacokinetics in the critically ill patient — Concepts appraised by the example of antimicrobial agents
Stijn Blot, Federico Pea, Jeffrey Lipman · 2014 · Advanced Drug Delivery Reviews · 420 citations
Critically ill patients are at high risk for development of life-threatening infection leading to sepsis and multiple organ failure. Adequate antimicrobial therapy is pivotal for optimizing the cha...
Reading Guide
Foundational Papers
Start with Roberts et al. (2014; DALI, 1034 citations) for ARC prevalence and beta-lactam failure evidence; Gonçalves-Pereira and Póvoa (2011) systematic review of beta-lactam PK heterogeneity; Ulldemolins et al. (2010) on compounding hypoalbuminemia.
Recent Advances
Abdul-Aziz et al. (2020; TDM position paper, 941 citations) for monitoring guidelines; Guilhaumou et al. (2019; French SFPT) optimization protocols; Timsit et al. (2020) on ARC in bloodstream infections.
Core Methods
8-hour CrCl measurement; continuous/prolonged beta-lactam infusions; TDM targeting 100% fT>MIC; population PK modeling (Roberts et al., 2014; Guilhaumou et al., 2019).
How PapersFlow Helps You Research Augmented Renal Clearance in Critically Ill
Discover & Search
Research Agent uses searchPapers('augmented renal clearance critically ill beta-lactam') to retrieve Roberts et al. (2014; 1034 citations), then citationGraph reveals forward citations like Abdul-Aziz et al. (2020). exaSearch('ARC CrCl measurement ICU') surfaces prevalence studies; findSimilarPapers expands to 50+ ARC papers.
Analyze & Verify
Analysis Agent applies readPaperContent on Roberts et al. (2014) to extract ARC prevalence (65%) and PK data, then runPythonAnalysis plots CrCl distributions vs. beta-lactam levels using pandas. verifyResponse with CoVe cross-checks claims against Gonçalves-Pereira (2011); GRADE grades evidence as high for ARC dosing impact.
Synthesize & Write
Synthesis Agent detects gaps like 'ARC in elderly ICU' via contradiction flagging across Blot et al. (2014) and Guilhaumou et al. (2019). Writing Agent uses latexEditText for dosing algorithm, latexSyncCitations for 20-paper bibliography, latexCompile for PDF; exportMermaid generates ARC predictor flowcharts.
Use Cases
"What CrCl threshold defines ARC and its beta-lactam impact in sepsis?"
Research Agent → searchPapers → readPaperContent (Roberts 2014) → runPythonAnalysis (CrCl histograms) → GRADE report: 130 mL/min threshold, 54% subtherapeutic piperacillin.
"Draft LaTeX guideline for ARC-adjusted meropenem dosing."
Synthesis Agent → gap detection → Writing Agent → latexGenerateFigure (infusion curves) → latexSyncCitations (Abdul-Aziz 2020) → latexCompile: 6g/day continuous infusion protocol PDF.
"Find Python code for ARC prediction from ICU datasets."
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect: Logistic regression model using age, SOFA score predicting ARC (linked from Blot 2014 citations).
Automated Workflows
Deep Research workflow scans 50+ ARC papers via searchPapers → citationGraph, generating structured review with prevalence meta-table (Roberts 2014 baseline). DeepScan's 7-steps verify PK claims: readPaperContent → runPythonAnalysis (fT>MIC simulations) → CoVe checkpoints. Theorizer builds dosing theory: 'ARC + hypoalbuminemia → 2x beta-lactam dose' from Ulldemolins (2010) + Guilhaumou (2019).
Frequently Asked Questions
What defines augmented renal clearance (ARC)?
ARC is CrCl >130 mL/min/1.73 m² measured over 8 hours in critically ill patients (Roberts et al., 2014).
What methods detect ARC in ICU?
8-hour urine collection for CrCl is gold standard; predictors include age <50, trauma, sepsis (Gonçalves-Pereira and Póvoa, 2011).
Key papers on ARC and antibiotics?
Roberts et al. (2014; DALI study, 1034 citations) shows 65% ARC prevalence, subtherapeutic beta-lactams; Abdul-Aziz et al. (2020) advocates TDM.
Open problems in ARC research?
Real-time bedside CrCl monitoring lacking; multivariate ARC prediction models <50% accurate; pediatric ARC data scarce (Blot et al., 2014).
Research Antibiotics Pharmacokinetics and Efficacy with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Augmented Renal Clearance in Critically Ill with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers